Yamazaki H - Search Results

1

Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.

Shimada T, Murayama N, Okada K, Funae Y, Yamazaki H, Guengerich FP. Shimada T, et al. Among authors: yamazaki h. Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10. Chem Res Toxicol. 2007. PMID: 17291012

2

Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Yamazaki H, Nakamura M, Komatsu T, Ohyama K, Hatanaka N, Asahi S, Shimada N, Guengerich FP, Shimada T, Nakajima M, Yokoi T. Yamazaki H, et al. Protein Expr Purif. 2002 Apr;24(3):329-37. doi: 10.1006/prep.2001.1578. Protein Expr Purif. 2002. PMID: 11922748

3

[P450 and carcinogenesis].

Yamazaki H, Kamataki T. Yamazaki H, et al. Nihon Yakurigaku Zasshi. 2002 Apr;119(4):208-12. doi: 10.1254/fpj.119.208. Nihon Yakurigaku Zasshi. 2002. PMID: 11979725 Review. Japanese.

4

Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

Kiyotani K, Yamazaki H, Fujieda M, Iwano S, Matsumura K, Satarug S, Ujjin P, Shimada T, Guengerich FP, Parkinson A, Honda G, Nakagawa K, Ishizaki T, Kamataki T. Kiyotani K, et al. Among authors: yamazaki h. Pharmacogenetics. 2003 Nov;13(11):689-95. doi: 10.1097/00008571-200311000-00005. Pharmacogenetics. 2003. PMID: 14583682

5

Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.

Kiyotani K, Fujieda M, Yamazaki H, Shimada T, Guengerich FP, Parkinson A, Nakagawa K, Ishizaki T, Kamataki T. Kiyotani K, et al. Among authors: yamazaki h. Drug Metab Pharmacokinet. 2002;17(5):482-7. doi: 10.2133/dmpk.17.482. Drug Metab Pharmacokinet. 2002. PMID: 15618701 Free article.

6

Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.

Miyazaki M, Yamazaki H, Takeuchi H, Saoo K, Yokohira M, Masumura K, Nohmi T, Funae Y, Imaida K, Kamataki T. Miyazaki M, et al. Among authors: yamazaki h. Carcinogenesis. 2005 Nov;26(11):1947-55. doi: 10.1093/carcin/bgi156. Epub 2005 Jun 15. Carcinogenesis. 2005. PMID: 15958517

7

Cytochrome P450 reconstitution systems.

Yamazaki H, Shimada T. Yamazaki H, et al. Methods Mol Biol. 2006;320:61-71. doi: 10.1385/1-59259-998-2:61. Methods Mol Biol. 2006. PMID: 16719374

8

Rat cytochrome P450 2C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol.

Yamazaki H, Shimizu M, Nagashima T, Minoshima M, Murayama N. Yamazaki H, et al. Drug Metab Dispos. 2006 Nov;34(11):1803-5. doi: 10.1124/dmd.106.011627. Epub 2006 Aug 8. Drug Metab Dispos. 2006. PMID: 16896062

9

CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl.

Nakajima M, Itoh M, Sakai H, Fukami T, Katoh M, Yamazaki H, Kadlubar FF, Imaoka S, Funae Y, Yokoi T. Nakajima M, et al. Among authors: yamazaki h. Int J Cancer. 2006 Dec 1;119(11):2520-6. doi: 10.1002/ijc.22136. Int J Cancer. 2006. PMID: 16988941 Free article.

10

Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.

Shimizu M, Yano H, Nagashima S, Murayama N, Zhang J, Cashman JR, Yamazaki H. Shimizu M, et al. Among authors: yamazaki h. Drug Metab Dispos. 2007 Mar;35(3):328-30. doi: 10.1124/dmd.106.013094. Epub 2006 Dec 1. Drug Metab Dispos. 2007. PMID: 17142560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,137 results

Search Page

Filters